MASI Stock Analysis: Buy, Sell, or Hold?

MASI - Masimo Corporation

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
$179.95
0.01 (0.01%) ▲
5d: +0.68%
30d: +0.92%
90d: +2.54%
WAIT
LOW Confidence
Analysis Updated: Jun 9, 2026 12:00 AM ET
Earnings: Aug 04, 2026 0d

Get Alerted When MASI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: MASI is fairly priced but lacks strong directional signals. At 1.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$236.63
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$146.93
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: MASI is currently trading at $179.95, which is considered fair based on recent price action. The stock's valuation (Forward PE: 27.3) is in line with its historical norms (26.3). At these levels, the market is pricing in 1.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, MASI is in a strong uptrend. The price is currently testing key support at $178.30. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: MASI scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 53/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 74.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • NEUTRAL: Near Wall St target ($180.00)
  • NEUTRAL: Market pricing in 1.2% annual earnings growth - fairly valued
  • WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market

Support & Resistance Levels

Support Level $178.30
Resistance Level $179.99
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) 27.26
Wall Street Target $180.00
Revenue Growth (YoY) 8.5%
Earnings Growth (YoY) 214.4%
Profit Margin 4.9%
Valuation Premium vs History +1.2% premium
PE vs Historical 27.3 vs 26.3 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.2% (market-implied from PE analysis)
1-Year Target $182.11 (+1%)
2-Year Target $184.29 (+2%)
3-Year Target $186.51 (+4%)
3-Yr Target (if PE normalizes) (PE: 27→26) PE COMPRESSION $179.95 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 27.3, Growth: 11.0%) $245.79 (+37%)
Base: (SPY PE: 21.9, Growth: 11.0%) $197.66 (+10%)
Bear: (PE: 18.6, Growth: 11.0%) $168.01 (-7%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 22, 2026 8:30 PM ET
Data refreshes hourly during market hours. Next update: 9:30 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MASI.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SYK
Stryker Corporation
BUY
32 analysts
$383 53 HOLD
DXCM
DexCom Inc
STRONG BUY
27 analysts
$94 31 SELL
ABT
Abbott Laboratories
STRONG BUY
27 analysts
$119 37 SELL
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$101 49 HOLD
MDT
Medtronic PLC
BUY
32 analysts
$98 35 SELL

More Analysis for MASI

MASI Technical Chart MASI Price Prediction MASI Earnings Date MASI Investment Advisor MASI Fair Price Analyzer MASI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals